Thermo Fisher (NYSE: TMO) insider Michel Lagarde files Form 144 to sell 22,046 shares

Rhea-AI Filing Summary

Thermo Fisher Scientific insider Michel Lagarde has filed a Form 144 indicating his intent to sell company stock. The notice covers 22,046 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of 12424320.59. The filing notes that 375708059 shares of common stock were outstanding.

Lagarde has also sold Thermo Fisher common shares in recent months. The notice lists sales of 4638 shares on 11/13/2025 for gross proceeds of 2756934.80, 30000 shares on 12/02/2025 for 17457612.00, and 32000 shares on 12/03/2025 for 18668515.20. By signing the notice, the seller represents that he is not aware of any material adverse, nonpublic information about the company’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	22046	12424320.59	375708059	12/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/04/2025	Option Granted - 03/23/2017	Issuer			22046	12/04/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michel Lagarde 168 Third Avenue Waltham MA 02451	Common	11/13/2025	4638	2756934.80
Michel Lagarde 168 Third Avenue Waltham MA 02451	Common	12/02/2025	30000	17457612.00
Michel Lagarde 168 Third Avenue Waltham MA 02451	Common	12/03/2025	32000	18668515.20

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Thermo Fisher (TMO) Form 144 filing disclose?

The Form 144 discloses that insider Michel Lagarde intends to sell 22,046 shares of Thermo Fisher common stock under Rule 144 through Fidelity Brokerage Services LLC on the NYSE.

How many Thermo Fisher (TMO) shares are covered by the new planned sale?

The notice covers 22,046 shares of Thermo Fisher common stock, with an aggregate market value reported as 12424320.59.

How many Thermo Fisher (TMO) shares were outstanding as referenced in the filing?

The filing states that 375,708,059 shares of Thermo Fisher common stock were outstanding.

What Thermo Fisher (TMO) stock sales by Michel Lagarde in the last 3 months are listed?

The filing lists prior sales of 4,638 shares on 11/13/2025 for 2756934.80, 30,000 shares on 12/02/2025 for 17457612.00, and 32,000 shares on 12/03/2025 for 18668515.20.

What acquisition details are provided for the Thermo Fisher (TMO) shares to be sold?

The 22,046 common shares were acquired via an option granted on 03/23/2017, with an acquisition date of 12/04/2025 and payment described as cash on 12/04/2025.

Does the Thermo Fisher (TMO) Form 144 include any representation about nonpublic information?

Yes. By signing, the seller represents that he does not know any material adverse information about Thermo Fisher’s current or prospective operations that has not been publicly disclosed.